Simon Stammen

Simon Stammen is an accomplished CMC Program Lead with extensive experience in the biotechnology sector. They served as a Director of CMC at BioNTech SE from 2022 to 2024 and held significant positions at CSL Behring, Sanofi, and Boehringer Ingelheim, including roles as Senior CMC Manager and Head of Molecular Biology. Simon earned a doctorate in Molecular and Microbiology from Technische Universität Carolo-Wilhelmina zu Braunschweig, where they also completed a degree in Biotechnology. Their career has been marked by leadership in molecular biology and microbial fermentation.